Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer

BACKGROUND: To evaluate the efficacy and safety of Icotinib – an orally administered, highly potent selective inhibitor of epidermal growth factor receptor (EGFR) and its active mutations, in the treatment of patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 101 patients...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Thorac Cancer
Main Authors: Qin, Na, Yang, Xinjie, Zhang, Quan, Li, Xi, Zhang, Hui, Lv, Jialin, Wu, Yuhua, Wang, Jinghui, Zhang, Shucai
Format: Artigo
Sprog:Inglês
Udgivet: BlackWell Publishing Ltd 2014
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704301/
https://ncbi.nlm.nih.gov/pubmed/26767007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12085
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker